Article
- The EMBO Journal (2000) 19, 4265 - 4271
- doi:10.1093/emboj/19.16.4265
Dominant-negative activity of an
1B-adrenergic receptor signal-inactivating point mutation
Songhai Chen1, Fang Lin1, Ming Xu1, John Hwa2 and Robert M. Graham1,3
- Molecular Cardiology Unit, Victor Chang Cardiac Research Institute, St Vincent's Hospital, Sydney 2010, Australia
- Departments of Biology and Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- School of Biochemistry and Molecular Genetics, University of New South Wales, Kensington, NSW 2033, Australia
Correspondence to:
Robert M. Graham, E-mail: b.graham@victorchang.unsw.edu.au
Received 23 May 2000; Accepted 23 June 2000; Revised 22 June 2000
Abstract
1-adrenergic receptors (
1-ARs) are members of the G-protein-coupled receptor (GPCR) superfamily and activate inositol phosphate (IP) turnover. We show that glycine and asparagine mutations of Phe303 in transmembrane segment VI (TMVI) of the
1B-AR, a highly conserved residue in GPCRs, although increasing agonist affinity, abolish agonist-activated IP signalling. Co-expression of the Phe303 mutants also inhibited (–)epinephrine-stimulated IP signalling by wild-type
1B-AR and other Gq-coupled receptors, as well as IP signalling mediated by AlF4- stimulation of both wild-type Gq
and a constitutively active mutant. The inability of the Phe303 mutants to signal is due to induction of a receptor conformation that dissociates G-protein binding from activation. As a result, the Phe303 mutants sequester Gq
and stoichiometrically inhibit Gq signalling in a dominant-negative manner. We further show that both the enhanced basal and agonist-stimulated IP-signalling activity of the constitutively active
1B-AR mutants, C128F and A293E, are inhibited in the double mutants, C128F/F303G and A293E/F303G. Phe303, therefore, appears to be critically involved in coupling TMVI
-helical movement, a key step in receptor activation, to activation of the cognate G-protein.
Keywords:
- constitutive activity,
- G-protein-coupled receptor,
- inositol phosphate signalling



